IPVS publishes a Policy Statement: Moving towards Elimination of Cervical Cancer as a Public Health Problem
IPVS is releasing a Call to Action to health authorities to adhere to international standards developed by WHO
The 32nd International Papillomavirus Conference is rapidly approaching and will take place in Sydney, Australia on 2-6 October 2018. This is a great opportunity for you to share your latest research and discoveries with colleagues and peers on a truly international stage!
With January being designated as National Cervical Health Awareness Month by the United States Congress, many activities took place around the country. We list here materials available online that provide more information.
IPVS President meets with the team of the PATH Scale-Up project that is assisting four countries in Central America and three African countries to introduce HPV testing.
Silvia de Sanjosé met with the Scale-Up project team. The Project seeks to reduce cervical cancer incidence through improved and expanded screening using HPV testing.
IPVS attends the Conference of the African Organization for Research and Training in Cancer (AORTIC) in Kigali, Rwanda
AORTIC’s 11th International Conference on Cancer in Africa (AORTIC 2017) took place from the 7th to 10th of November 2017 at the Kigali Convention Centre in Kigali, Rwanda, with a pre-conference symposium on the 6th November 2017.
IPVS members and their colleagues should be aware that there are several for-profit publishers and conference organizers that have identified HPV researchers as a potential clientele for their spam emails.
Congratulations to Dr. Eduardo Franco, who receives the award for Distinguished Service to Cancer Research
IPVS offers Sponsorship Prize and Best Oral Presentation Prize at DNA Tumor Virus Meeting, in Birmingham, UK
IPVS sponsored awards as part of its mission to promote and support education about papillomaviruses and career development in all aspects of papillomavirus-related research including basic science.